G-NEXT™-Platform

GeneMedi’s Novel Evolution-X Technology for discovery of next generation of AAV. X refers to the exploring of AAV for more possibilities with GeneMedi’s innovational strategies.

1) AAV-biology based screening, rational-design and evolution
2) hiPSCs based human cell models for reliable screening and validation
3) Structure based site-engineering and immunogenic epitope modification
4) High throughput AAV Manufacturing & high frequency of AAV-evolution.